LAXAI is a global Functional Service Provider of Drug R & D and Clinical Research services that enable biopharmaceutical companies to drive drugs to market cost effectively and efficiently.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

DRUG SHORTAGES IN US MARKET, COMPLIANCE GAINS POSITIVE FOR PHARMA EXPORTERS

Business-standard | April 23, 2020

news image

Concerns over price erosion in the US market, which has impacted the revenue growth of Indian pharma majors over the last four years, could be reversing. The drug shortages in the US market have increased by 37 per cent since December 2017. Kunal Randeria of Antique Stock Broking says drug shortages are at five-year highs and there is a direct correlation between drug shortage and prices. This is evident as price erosion peaked in 2017 when shortages were at their lowest levels. Concerns over pr...

Read More

US WILL BE WORLD'S PREMIER PHARMACY DRUG STORE AND MEDICAL MANUFACTURER: TRUMP

cnbctv18 | May 21, 2020

news image

The COVID-19 pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation, US President Donald Trump said on Thursday declaring the goal of making his country the world's premier pharmacy, drug store, and medical manufacturer. "The global pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation.... Today, I'm declaring a simple but vital national goal. The United States will be the world's ...

Read More

Business Insights

SANDOZ TARGETS GROWTH OPPORTUNITIES IN RESPIRATORY AND COMPLEX GENERICS THROUGH ACQUISITION OF RESPIRATORY DEVICE COMPANY COALESCE

Novartis Pharma AG | March 14, 2022

news image

Sandoz, a Novartis division, announced that it has successfully acquired the UK-based medical and drug delivery device development company, Coalesce Product Development Limited. Through this deal, Sandoz has acquired the significant capabilities and assets of Coalesce, which will help it build on its existing portfolio of respiratory medicines and further improve patient access to these high-quality, complex therapies. “Respiratory and co...

Read More

VIEWS AND ANALYSIS, PHARMACY MARKET

VINCERX PHARMA PRESENTS PRECLINICAL DATA ON VIP943 IN ACUTE MYELOID LEUKEMIA MODELS AT THE 64TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING 2022

Vincerx Pharma, Inc. | December 12, 2022

news image

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced a poster presentation of preclinical data of Vincerx’s proprietary payload and linker technology and VIP943, the Company’s internalizing ADC targeting CD123, at the 64th American Society of Hematology Annual Meeting 2022. VIP943 is a novel ADC, which binds to the IL3-receptor alpha chain . VIP943 co...

Read More
news image

DRUG SHORTAGES IN US MARKET, COMPLIANCE GAINS POSITIVE FOR PHARMA EXPORTERS

Business-standard | April 23, 2020

Concerns over price erosion in the US market, which has impacted the revenue growth of Indian pharma majors over the last four years, could be reversing. The drug shortages in the US market have increased by 37 per cent since December 2017. Kunal Randeria of Antique Stock Broking says drug shortages are at five-year highs and there is a direct correlation between drug shortage and prices. This is evident as price erosion peaked in 2017 when shortages were at their lowest levels. Concerns over pr...

Read More
news image

US WILL BE WORLD'S PREMIER PHARMACY DRUG STORE AND MEDICAL MANUFACTURER: TRUMP

cnbctv18 | May 21, 2020

The COVID-19 pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation, US President Donald Trump said on Thursday declaring the goal of making his country the world's premier pharmacy, drug store, and medical manufacturer. "The global pandemic has proven once and for all that to be a strong nation, America must be a manufacturing nation.... Today, I'm declaring a simple but vital national goal. The United States will be the world's ...

Read More
news image

Business Insights

SANDOZ TARGETS GROWTH OPPORTUNITIES IN RESPIRATORY AND COMPLEX GENERICS THROUGH ACQUISITION OF RESPIRATORY DEVICE COMPANY COALESCE

Novartis Pharma AG | March 14, 2022

Sandoz, a Novartis division, announced that it has successfully acquired the UK-based medical and drug delivery device development company, Coalesce Product Development Limited. Through this deal, Sandoz has acquired the significant capabilities and assets of Coalesce, which will help it build on its existing portfolio of respiratory medicines and further improve patient access to these high-quality, complex therapies. “Respiratory and co...

Read More
news image

VIEWS AND ANALYSIS, PHARMACY MARKET

VINCERX PHARMA PRESENTS PRECLINICAL DATA ON VIP943 IN ACUTE MYELOID LEUKEMIA MODELS AT THE 64TH AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING 2022

Vincerx Pharma, Inc. | December 12, 2022

Vincerx Pharma, Inc. a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced a poster presentation of preclinical data of Vincerx’s proprietary payload and linker technology and VIP943, the Company’s internalizing ADC targeting CD123, at the 64th American Society of Hematology Annual Meeting 2022. VIP943 is a novel ADC, which binds to the IL3-receptor alpha chain . VIP943 co...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us